Heterojunction-driven MXenzyme biocatalysis: a progressive strategy to remodel tumor immune microenvironments for improved therapeutic efficacy.

The hypoxic and immunosuppressive tumor microenvironment (TME) significantly impedes reactive oxygen species (ROS) generation and suppresses the release of tumor-associated antigens, thereby limiting the induction of immunogenic cell death (ICD) and…

Preview only. Read the full abstract at the source